62/100B416.68
USD
0.61
(0.15%)
Market Closed
Last updated: · Delayed 15 min
BeiGene revenue 2013–2026What is revenue? Revenue is the money a company brings in from selling its goods and services over a period, before any costs. It is the top line of the income statement.
BeiGene's revenue in Q3 FY2026, the three months to 30 September 2026, was 1.89B USD, up 33.8% on the same quarter a year before. BeiGene's revenue over the last twelve months was 6.61B USD, up 32.9% on the twelve months before. In fiscal year 2025 it was 5.34B USD, up 40.2% on the year before.
Last updated 12 Nov 2026 · Next report 25 Feb 2027
Revenue
Growth
| Fiscal year | Period ending | Revenue | Growth | Gross profit | Net income |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 6.61B | +32.86% | 5.91B | 915.57M |
| FY2025 | 31 Dec 2025 | 5.34B | +40.23% | 4.67B | 286.93M |
| FY2024 | 31 Dec 2024 | 3.81B | +54.96% | 3.22B | -644.79M |
| FY2023 | 31 Dec 2023 | 2.46B | +73.65% | 2.08B | -881.71M |
| FY2022 | 31 Dec 2022 | 1.42B | +20.37% | 1.13B | -2.00B |
| FY2021 | 31 Dec 2021 | 1.18B | +280.83% | 1.01B | -1.46B |
| FY2020 | 31 Dec 2020 | 308.87M | -27.87% | 238.22M | -1.62B |
| FY2019 | 31 Dec 2019 | 428.21M | +116.03% | 357.02M | -948.63M |
| FY2018 | 31 Dec 2018 | 198.22M | -16.85% | -509.49M | -673.77M |
| FY2017 | 31 Dec 2017 | 238.39M | +22,179.16% | -35.61M | -93.11M |
| FY2016 | 31 Dec 2016 | 1.07M | -87.86% | -96.96M | -119.22M |
| FY2015 | 31 Dec 2015 | 8.82M | -32.37% | -49.43M | -57.10M |
| FY2014 | 31 Dec 2014 | 13.04M | +16.93% | -8.83M | -18.28M |
| FY2013 | 31 Dec 2013 | 11.15M | — | -2.32M | -7.49M |
| Quarter | Period ending | Revenue | Growth on a year before | Gross profit | Net income |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.89B | +33.81% | 1.67B | 384.71M |
| Q2 FY2026 | 30 Jun 2026 | 1.71B | +29.63% | 1.53B | 237.01M |
| Q1 FY2026 | 31 Mar 2026 | 1.51B | +35.46% | 1.35B | 227.36M |
| Q4 FY2025 | 31 Dec 2025 | 1.50B | +32.84% | 1.36B | 66.50M |
| Q3 FY2025 | 30 Sept 2025 | 1.41B | +41.00% | 1.22B | 124.84M |
| Q2 FY2025 | 30 Jun 2025 | 1.32B | +41.56% | 1.15B | 94.32M |
| Q1 FY2025 | 31 Mar 2025 | 1.12B | +48.64% | 952.28M | 1.27M |
| Q4 FY2024 | 31 Dec 2024 | 1.13B | +77.78% | 967.26M | -151.88M |
| Q3 FY2024 | 30 Sept 2024 | 1.00B | +28.20% | 831.14M | -121.35M |
| Q2 FY2024 | 30 Jun 2024 | 929.17M | +56.09% | 791.03M | -120.41M |
| Q1 FY2024 | 31 Mar 2024 | 751.65M | +67.85% | 626.72M | -251.15M |
| Q4 FY2023 | 31 Dec 2023 | 634.41M | +66.91% | 528.58M | -367.55M |
| Q3 FY2023 | 30 Sept 2023 | 781.31M | +101.56% | 685.00M | 215.41M |
| Q2 FY2023 | 30 Jun 2023 | 595.26M | +74.27% | 499.27M | -381.14M |
| Q1 FY2023 | 31 Mar 2023 | 447.80M | +46.04% | 366.01M | -348.43M |
| Q4 FY2022 | 31 Dec 2022 | 380.10M | +77.63% | 306.57M | -445.34M |
| Q3 FY2022 | 30 Sept 2022 | 387.63M | +87.77% | 311.09M | -557.56M |
| Q2 FY2022 | 30 Jun 2022 | 341.57M | +127.73% | 270.40M | -565.73M |
| Q1 FY2022 | 31 Mar 2022 | 306.63M | -49.39% | 241.39M | -435.20M |
| Q4 FY2021 | 31 Dec 2021 | 213.98M | +113.77% | 165.43M | -585.65M |
| Q3 FY2021 | 30 Sept 2021 | 206.44M | +126.66% | 159.03M | -438.11M |
| Q2 FY2021 | 30 Jun 2021 | 149.99M | +128.52% | 113.73M | -480.34M |
| Q1 FY2021 | 31 Mar 2021 | 605.87M | +1,063.82% | 573.19M | 66.50M |
| Q4 FY2020 | 31 Dec 2020 | 100.10M | +75.95% | 79.02M | -472.75M |
| Q3 FY2020 | 30 Sept 2020 | 91.08M | +81.65% | 69.96M | -425.22M |
| Q2 FY2020 | 30 Jun 2020 | 65.64M | -73.03% | 51.33M | -335.20M |
| Q1 FY2020 | 31 Mar 2020 | 52.06M | -33.11% | 37.91M | -363.74M |
| Q4 FY2019 | 31 Dec 2019 | 56.89M | -3.03% | 38.91M | -388.06M |
| Q3 FY2019 | 30 Sept 2019 | 50.14M | -7.49% | -206.93M | -307.36M |
| Q2 FY2019 | 30 Jun 2019 | 243.35M | +360.85% | -3.25M | -85.57M |
| Q1 FY2019 | 31 Mar 2019 | 77.83M | +139.16% | -115.78M | -167.64M |
| Q4 FY2018 | 31 Dec 2018 | 58.67M | +222.82% | -207.99M | -268.26M |
| Q3 FY2018 | 30 Sept 2018 | 54.20M | -75.39% | -102.09M | -144.03M |
| Q2 FY2018 | 30 Jun 2018 | 52.80M | — | -117.70M | -156.89M |
| Q1 FY2018 | 31 Mar 2018 | 32.54M | — | -81.71M | -104.60M |
| Q4 FY2017 | 31 Dec 2017 | 18.17M | — | -76.20M | -99.32M |
| Q3 FY2017 | 30 Sept 2017 | 220.21M | — | 130.61M | 117.39M |
| Q2 FY2017 | 30 Jun 2017 | 0.00 | -100.00% | -47.25M | -60.55M |
| Q1 FY2017 | 31 Mar 2017 | 0.00 | -100.00% | -42.77M | -50.62M |
| Q4 FY2016 | 31 Dec 2016 | 0.00 | -100.00% | -28.93M | -37.60M |
| Q3 FY2016 | 30 Sept 2016 | 0.00 | -100.00% | -30.11M | -35.49M |
| Q2 FY2016 | 30 Jun 2016 | 393.00K | -71.52% | -20.72M | -24.12M |
| Q1 FY2016 | 31 Mar 2016 | 677.00K | -50.91% | -17.20M | -22.00M |
| Q4 FY2015 | 31 Dec 2015 | 4.68M | +238.67% | -23.43M | -27.25M |
| Q3 FY2015 | 30 Sept 2015 | 1.38M | -78.76% | -11.97M | -14.00M |
| Q2 FY2015 | 30 Jun 2015 | 1.38M | -46.49% | -5.36M | -5.64M |
| Q1 FY2015 | 31 Mar 2015 | 1.38M | -46.53% | -8.68M | -10.21M |
| Q4 FY2014 | 31 Dec 2014 | 1.38M | — | -4.83M | -3.75M |
| Q3 FY2014 | 30 Sept 2014 | 6.50M | — | -1.92M | -9.76M |
| Q2 FY2014 | 30 Jun 2014 | 2.58M | — | -1.04M | -2.38M |
| Q1 FY2014 | 31 Mar 2014 | 2.58M | — | -1.04M | -2.38M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
BeiGene revenue growth by segment
Q3 FY2026 against Q3 FY2025
Product2.44B
+37.6%
BeiGene revenue by segment over time
Product Collaboration
See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement
Common questions about BeiGene's revenue
Source: Financial Modeling Prep